-
8 Comments
Intuitive Surgical, Inc is currently in a long term uptrend where the price is trading 21.1% above its 200 day moving average.
From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 20.6.
Intuitive Surgical, Inc's total revenue rose by 4.0% to $1B since the same quarter in the previous year.
Its net income has increased by 3.6% to $371M since the same quarter in the previous year.
Finally, its free cash flow fell by 30.4% to $286M since the same quarter in the previous year.
Based on the above factors, Intuitive Surgical, Inc gets an overall score of 4/5.
Linda Krehbiel
Follow
3 years, 3 months ago
|
George Ponderevo
Follow
3 years, 3 months ago
|
Sector | Healthcare |
---|---|
ISIN | US46120E6023 |
CurrencyCode | USD |
Exchange | NASDAQ |
Industry | Medical Instruments & Supplies |
Market Cap | 92B |
---|---|
Target Price | 277.47 |
Beta | 1.29 |
PE Ratio | 70.56 |
Dividend Yield | 0.0% |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ISRG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024